A novel RET gene mutation in a patient with apparently sporadic pheochromocytoma-Reference-Cited by-同舟云学术

A novel RET gene mutation in a patient with apparently sporadic pheochromocytoma

Published:2016 Issue:1 Volume:63 Page:87-91
ISSN:0918-8959
Container-title:Endocrine Journal
language:en
Short-container-title:Endocr J

Author:

Scollo Claudia¹,Russo Marco²,De Gregorio Laura³,Terranova Rosa³,Mangione Erika³,Castoro Carlotta³,Squatrito Sebastiano³,Pellegriti Gabriella¹

Affiliation:

1. Endocrinology, Garibaldi Nesima Hospital, Catania, Italy

2. Endocrinology, Department of Clinical and Experimental Medicine, University of Messina, Italy

3. Endocrinology, Department of Clinical and Experimental Medicine, University of Catania, Italy

Publisher

Japan Endocrine Society

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

https://www.jstage.jst.go.jp/article/endocrj/63/1/63_EJ15-0399/_pdf

Reference23 articles.

1. 1. De Lellis RA, Lloyd RV, Heitz PU & Eng C eds (2004) Pathology and Genetics of Tumours of Endocrine Organs. World Health Organization Classification of Tumours. IARC Press, Lyon.

2. 2. Jafri M, Maher ER (2012) The genetics of phaeochromocytoma: using clinical features to guide genetic testing. Eur J Endocrinol 166:151-158.

3. 3. Bravo EL (1994) Evolving concepts in the pathophysiology, diagnosis, and treatment of pheochromocytoma. Endocr Rev 15:356-368.

4. 4. Pacak K, Eisenhofer G, Ahlman H, Bornstein SR, Gimenez-Roqueplo AP, et al. (2007) Pheochromocytoma: recommendations for clinical practice from the First International Symposium. October 2005. Nat Clin Pract Endocrinol Metab 3:92-102.

5. 5. Mulligan LM, Kwok JB, Healey CS, Elsdon MJ, Eng C, et al. (1993) Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A. Nature 363:458-460.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mechanism of RET gene mediated EGFR signaling pathway on epithelial-mesenchymal transition, proliferation and apoptosis of papillary thyroid carcinoma cells;EUR REV MED PHARMACO;2020

2. A Novel RET D898Y Germline Mutation in a Patient with Pheochromocytoma;Case Reports in Endocrinology;2018